With a market cap of 55.98 B, Biogen Inc. has a large market cap size. Biogen Inc. (NASDAQ: BIIB) has been on the stock market since its IPO date on the 9/17/1991. Biogen Inc. is in the Biotechnology industry and Healthcare sector. Average volume for Biogen Inc., is 1577.26, and so far today it has a volume of 1956199. Performance year to date since the 9/17/1991 is -0.25%.
To help you determine whether Biogen Inc. is undervalued the following values will help you decide. P/E is 16.34 and forward P/E is 11.57. PEG perhaps more useful shows that Biogen Inc. has a value for PEG of 2.58. P/S ratio is 4.85 and the P/B ratio is 4.89. The P/Cash and P/Free cash flow is 19.44 and 44.16 respectively.
At the current price Biogen Inc. is trading at, 260.54 (3.50% today), Biogen Inc. has a dividend yield of *TBA, and this is covered by a payout ratio of 0.00%. Earnings per share (EPS) is 15.95, and this is looking to grow in the next year to 9.90% after growing 10.30% this past year. EPS growth quarter over quarter is -21.80%, and 3.10% for sales growth quarter over quarter.
The number of shares outstanding is 214.88, and the number of shares float is 211.49. The senior management bring insider ownership to 0.10%, and institutional ownership is at 90.50%. The float short is 1.15%, with the short ratio at a value of 1.54. Management has seen a return on assets of 15.90%, and also a return on investment of 21.00%.
The ability for Biogen Inc., to deal with debt, means it current ratio is 2.3, and quick ratio is 2. Long term debt/equity is 0.52 and total debt/equity is 0.57. In terms of margins, Biogen Inc. has a gross margin of 86.60%, with its operating margin at 41.60%, and Biogen Inc. has a profit margin of 30.20%.
The 52 week high is -15.22%, with 26.83% being its 52 week low. The 20 day simple moving average is 2.57% and the 200 day simple moving average is -4.24%.
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.